← Leaderboards
Charlton Lam
Ohio State University
$75,282
Attributed
$75,282
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.9K · FY2024–25$50K$37.5K$25K$12.5K$0
'24
'25
Funding mix
By agency
NIH$75,282 · 1
By mechanism
F31$75,282 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Paul A Fuerst$1,931,760
- Michael A Caligiuri$65,062,344
- Daniel J Wozniak$19,868,004
- Michael Ibba$5,138,456
- Katherine Hunold Buck$1,252,845
Others in their field
Other Rising Stars on “Adsorption”
- Anat R. Tambur · Northwestern University At Chicago$2,399,982
- Jeff T Hutchins · Inhalon Biopharma, Inc.$2,042,193
- Choon-Sik Jhun · Pennsylvania State Univ Hershey Med Ctr$1,936,803
- Xuanren Goodman · University Of Delaware$1,800,000
- Melissa A Petruska · Sonata Scientific, Llc$1,710,218
- Idil D Akin · Washington State University$1,679,457
Research focus
AdsorptionAlternative TherapiesAlternative TreatmentAntagonistAnti-Bacterial AgentsAntimicrobialAnti-Microbial DrugAnti-Microbial PeptideAntimicrobial ResistanceBacteriaBacterial InfectionsBactericideBacteriophagesBiofilm SpeciesBiological AvailabilityBiomassBody FluidsCandidaCandida AlbicansCandida AurisCandida BiofilmCo-InfectionCombatAdopted
Grant awards (2)
Development of novel bacteriophage-based therapies to combat Pseudomonas aeruginosa and Candida spp. dual-species biofilms.$37,923
F31 · FY2025 · AI · contact PI
Development of novel bacteriophage-based therapies to combat Pseudomonas aeruginosa and Candida spp. dual-species biofilms.$37,359
F31 · FY2024 · AI · contact PI